Overview
In our project, we
developed a capsule containing two catalytic enzymes
dextransucrase and
inulosucrase that are coded by genes
EC.2.4.1.5 and EC.2.4.1.9 to catalyse the
conversion from sucrose to two types of soluble dietary fibres
(SDFs) dextran and inulin respectively as shown in
Figure 1. Therefore, individuals may enjoy their diets without change in flavor while reducing the human
body's effective absorption of sugars in food and increasing fibre intake. With no change to the sugar
content of the food, this initiative intends to promote bowel movement, regulate gut bacteria, and lower
the quantity of sugar absorbed by the human body into the bloodstream.
Figure
1 The
overview flowchart of
our experiment
Construction of plasmids
We
designed 2
plasmids: pET28a-EC.2.4.1.5 and pET28a-EC.2.4.1.9. The
DNA fragments EC.2.4.1.5 and EC.2.4.1.9 are amplified from the genome of Leuconostoc citreum[1]and
the
genome of Lactobacillus
johnsonii[2].
-
Identification and pre-modification of target genes
To construct our plasmids, we let
the company synthesise the
DNA fragments. To excise
two bands of interest (EC.2.4.1.5, EC.2.4.1.9), we used restriction endonuclease NdeⅠ and
XhoⅠ
to cut the DNA fragments and the
pET28a vector.
Theoretically, the gene fragment
lengths for EC.2.4.1.5 and EC.2.4.1.9 are 4431bp and
2391bp, respectively.
After PCR
amplification, the TAE agarose gel electrophoresis results (Figure 2) proved the theoretical values, and
we could continue our experiment. After DNA extraction from the gel, T4 ligase was used to link the
vector and the target genes (EC.2.4.1.5 and EC.2.4.1.9) to produce the recombinant plasmid.
Figure
2.
The identification of plasmid pET-28a, gene fragments
EC.2.4.1.5 and EC.2.4.1.9 by restriction
enzymes digestion
and PCR amplification.
M: Maker;
EC.2.4.1.5:
Gene fragment EC.2.4.1.5 that digested
by Restriction
endonuclease NdeⅠ and
XhoⅠ. EC.2.4.1.9: Gene fragment EC.2.4.1.9
that digested by
Restriction endonuclease NdeⅠ and XhoⅠ.
-
Plasmid profile
At the same time, Snapgene was used to create the profiles of the plasmids
pET28a-EC.2.4.1.5 and pET28a-EC.2.4.1.9
so that parts of
the plasmids, including the target gene, restriction gene, and multiple cloning site, were
demonstrated
and understood.
Figure
3.
Plasmid profile
of pET28a-EC.2.4.1.5(left) and
pET28a-EC.2.4.1.9(right).
-
Plasmid transformation
In this part, we transformed the plasmids constructed
into
DH5α E.coli and replicated them. After extracting
and verifying the
plasmids, we transformed the plasmids into the bacteria again.
The
recombinant plasmid was transformed into
E.coli (DH5α),
and we incubated them overnight at 37°C
after streak inoculating them on LB solid
medium plates that
included appropriate
antibiotics (LB-kana), as shown in
Figure 4. Afterward, we picked 3 individual colonies from each petri dish and
extracted their plasmids. A gel electrophoresis was run to confirm that the extracted plasmids were the
ones we required. As EC.2.4.1.5 and EC.2.4.1.9 have DNA fragment
lengths of 4431bp and 2391bp, our results show that we get the desired plasmids. The
DNA
sequencing diagram shows the desired lengths and sequencing for pET28a-EC.2.4.1.5 and pET28a-EC.2.4.1.9
(Figure 5) indicates the plasmid construction of pET28a-EC.2.4.1.5 and pET28a-EC.2.4.1.9 are
successful.
Figure
4.
Incubate the
plasmids containing strains and gel
electrophoresis. A: Gel electrophoresis
was used to
confirm that the extracted plasmids were the ones we required. B:
pET28a-EC.2.4.1.5 containing strain. C:
pET28a-EC.2.4.1.9 containing
strain.
Figure
5.
The DNA sequencing
diagram for pET28a-EC.2.4.1.9
Protein expression and purification
-
Expression of protein
The recombinant
plasmid
was first transformed into E.coli BL21(DE3), incubated on LB solid medium plates (Kana+), and cultured at 37°C overnight. Four colonies of each
desired
plasmid were selected for PCR identification of transformants to confirm that the colonies have positive
results (shown in Figure 6) and then transferred into 1L
fresh LB
(Kana+) culture medium for the scale-up
cultivation. IPTG (0.2 mM) was used
to induce the
expression of genes EC.2.4.1.5 and EC.2.4.1.9
with OD600
around 0.6-0.8 and
cultured at 16℃ for 20h. The proteins were then extracted from the supernatant of the E.coli BL21(DE3) after ultrasonic cell disruption and
centrifugation.
Figure
6.
DNA gel electrophoresis to verify the construction of
correct
recombinant plasmids from E.coli BL21(DE3). A: DNA gel electrophoresis
verification of genes. B: E.coli BL21(DE3) that
contain EC.2.4.1.5 and EC.2.4.1.9
-
Protein purification
Nickel affinity chromatography is used to purify the
protein
sample we got for a clearer SDS-PAGE result with little interference by non-specifically bound
proteins. In Figure 7, the bands with sizes of 167 kDa and 88 kDa for dextransucrase and inulosucrase demonstrate that the expected
proteins are expressed and
collected. The target proteins (dextransucrase and
inulosucrase) are successfully expressed and confirmed by the target bands
shown in the supernatant and flowthrough part. In the wash part, some target proteins are washed away
with other non-specific proteins, and in the elution part, a single and clear band illustrating the
target protein with the expected size for both dextransucrase and inulosucrase, which have sizes of
167 kDa and 88 kDa.
Figure 7 Results
of
SDS-PAGE of supernatant, flowthrough,
wash, and elution parts for the protein purification of dextransucrase and inulosucrase extracted
from EC.2.4.1.5 and EC.2.4.1.9 in E.coli
BL21(DE3)
Functional verification of enzymes
Both enzymes convert sucrose to 50% monosaccharides
and 50%
SDFs, while a lower proportion of monosaccharides
could be achieved by combining the two enzymes in an ideal
ratio. Thin-layer chromatography and high-performance liquid
chromatography (HPLC) were carried out to find the optimum ratio and
conditions.
-
Thin-layer chromatography
In a standard 2%
sucrose
solution, a certain amount of
two recombinant enzyme
solutions with the ratio of 1:1, 1:2, and 2:1
between concentrations of dextransucrase and
inulosucrase was added, and the reaction was shaken at 37°C for 1h. After the reaction, thin-layer chromatography
detected
the sucrose changes in the reaction solution and the glucose content generated qualitatively. Figure 8
shows that the group with the least sucrose concentration undigested has a ratio of 2:1 between
dextransucrase and
inulosucrase.
Figure 8.
Thin-layer
chromatography is used to identify the efficiency of different recombinant enzyme
solutions. 1: The recombinant enzyme
solution with a ratio of 1:1
between dextransucrase and inulosucrase. 2: The recombinant enzyme solution with a ratio of 1:2
between dextransucrase and inulosucrase. 3: The recombinant enzyme solution with a ratio of 2:1
between dextransucrase and inulosucrase.
-
High-performance liquid chromatography
In addition,
sugarcane
juice was used as a type of simulated food suspension to test enzyme function in real conditions. The
experiment took place under 37℃ to
simulate human body temperature. A 1:1 ratio of concentration between dextransucrase and inulosucrase is used with masses of 1mg,
5mg, 10mg, 15mg, and 20 mg of each
type of enzyme per 100 g sugarcane juice for 5 minutes, 10 mins, 15 mins, 30 mins, and 60 mins. Once the
reaction time is reached, the solution is immediately heated to 65℃ to
denature the enzymes. Afterward, HPLC is carried out to analyse the amount of sucrose and glucose
contained in the solution, the raw data are listed below (Table 1). We
used Origin Pro to
process data, forming 3D mappings about glucose and sucrose
concentrations in
various conditions (Figure 8). By analysing
the raw data and the 3D mapping, we could conclude that in general, with a longer reaction time,
catalysing tends to become more complete, which means higher glucose concentration while lower sucrose
concentration. In speaking of
each enzyme's sample size, except for the extremely high remaining sucrose with 1mg of
dextransucrase and inulosucrase, it is difficult to summarise the overall effects of the change in
glucose and sucrose concentrations. A low sucrose concentration (0g/100g) was left in the solution
when 20 mg of each enzyme was left in the solution and reacted for 60 mins, but a higher glucose
concentration was formed (2.9g/100g).
Table 1 The amount
of
sucrose and glucose contained in 100 g sugarcane solution with the existence of dextransucrase and
inulosucrase at 37℃.
Sugarcane juice
(100g)
|
Sugarcane juice (100g)
|
Sample size of each
enzyme (mg)
|
Reaction time (min)
|
Sucrose remained (g)
|
Sample size of each enzyme (mg)
|
Reaction time (min)
|
Glucose produced (g)
|
1
|
5
|
0.76
|
1
|
5
|
2.4
|
10
|
0.74
|
10
|
2.5
|
15
|
0.72
|
15
|
2.8
|
30
|
0.71
|
30
|
2.8
|
60
|
0.24
|
60
|
3.4
|
5
|
5
|
0.53
|
5
|
5
|
2.5
|
10
|
0.43
|
10
|
2.6
|
15
|
0.41
|
15
|
2.4
|
30
|
0.42
|
30
|
2.9
|
60
|
0.41
|
60
|
3.9
|
10
|
5
|
0.5
|
10
|
5
|
2.7
|
10
|
0.42
|
10
|
2.7
|
15
|
0.088
|
15
|
2.6
|
30
|
0.47
|
30
|
2.7
|
60
|
0.43
|
60
|
2.7
|
15
|
5
|
0.39
|
15
|
5
|
2.3
|
10
|
0.4
|
10
|
2.5
|
15
|
0.43
|
15
|
2.5
|
30
|
0.43
|
30
|
2.7
|
60
|
0.38
|
60
|
2.7
|
20
|
5
|
0.38
|
20
|
5
|
2.6
|
10
|
0.44
|
10
|
2.4
|
15
|
0.41
|
15
|
2.6
|
30
|
0.35
|
30
|
2.6
|
60
|
0
|
60
|
2.9
|
However, when the
sample
size is 10 mg for each enzyme, noticeably low remaining sucrose (0.088g/100g) and relatively low glucose
production (2.6g/100g) are observed when the reaction time is 15 mins. In conclusion, we determined that
allowing 10 mg of each enzyme to react in sugarcane juice for 15 mins is ideal to guarantee little
sucrose sustain and glucose synthesis at 37°C.
Figure
9 3D
mapping of
glucose(right) and sucrose(left) concentrations in various conditions under 37°C.
Future plans
Subsequently, we may
start the construction of the capsule to protect two protein-based enzymes from denaturation by the low
pH of gastric juice by adopting the microencapsulation technique, in which enzymes are coated in small
spheres. The capsule made of calcium chloride and sodium alginate provides high strength, elasticity,
and thermal stability to resist pepsin and hydrochloric acid in the stomach [3]. Moreover, the effect of
recombinant enzymes in the actual environment of the gastrointestinal tract should also be tested in the
future with distinct approaches, including the in vitro method, animal experiments,
and
human clinical
trials.
References
-
‘dextransucrase [Leuconostoc citreum] - Protein - NCBI’. Accessed: Jul. 26, 2024.
[Online].
-
‘glycoside hydrolase family 68 protein [Lactobacillus johnsonii] - Protein - NCBI’.
Accessed: Jul. 26, 2024. [Online]
-
YANG B. et al., ‘Preparation and
properties of lipase microcapsules,’ China Dairy
Industry, vol. 51, no. 9, pp. 10-14+64, 2023.